Cover Image

Liraglutide exerts an anti-inflammatory action in obese patients with type 2 diabetes

Introduction. Liraglutide (L) is the analogue of human glucagon-like peptide 1 which stimulates glucose-dependent insulin secretion and can modify the level of inflammatory biomarkers.

Saved in:
Bibliographic Details
Main Authors: Savchenko Liudmyla G. (Author), Digtiar Nataliia I. (Author), Selikhova Liudmyla G. (Author), Kaidasheva Elvira I. (Author), Shlykova Oksana A. (Author), Vesnina Liudmyla E. (Author), Kaidashev Igor P. (Author)
Format: Book
Published: Sciendo, 2019-09-01T00:00:00Z.
Subjects:
article
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_63f4a69ceca24903b938ec99a2d0ff9a
042 |a dc 
100 1 0 |a Savchenko Liudmyla G.  |e author 
700 1 0 |a Digtiar Nataliia I.  |e author 
700 1 0 |a Selikhova Liudmyla G.  |e author 
700 1 0 |a Kaidasheva Elvira I.  |e author 
700 1 0 |a Shlykova Oksana A.  |e author 
700 1 0 |a Vesnina Liudmyla E.  |e author 
700 1 0 |a Kaidashev Igor P.  |e author 
245 0 0 |a Liraglutide exerts an anti-inflammatory action in obese patients with type 2 diabetes 
260 |b Sciendo,   |c 2019-09-01T00:00:00Z. 
500 |a 2501-062X 
500 |a 10.2478/rjim-2019-0003 
520 |a Introduction. Liraglutide (L) is the analogue of human glucagon-like peptide 1 which stimulates glucose-dependent insulin secretion and can modify the level of inflammatory biomarkers. 
546 |a EN 
690 |a glucagon-like peptide 1 (glp-1) 
690 |a liraglutide 
690 |a diabetes 
690 |a obesity 
690 |a nf-kb 
690 |a sirt1 
690 |a mediators of inflammation 
690 |a Internal medicine 
690 |a RC31-1245 
655 7 |a article  |2 local 
786 0 |n Romanian Journal of Internal Medicine, Vol 57, Iss 3, Pp 233-240 (2019) 
787 0 |n https://doi.org/10.2478/rjim-2019-0003 
787 0 |n https://doaj.org/toc/2501-062X 
856 4 1 |u https://doaj.org/article/63f4a69ceca24903b938ec99a2d0ff9a  |z Connect to this object online. 

Similar Items